Dna Group (T.R.) Ltd (TLV:DNA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 111.00
+1.30 (1.19%)
Dec 4, 2025, 5:24 PM IDT
Dna Group (T.R.) Revenue
Dna Group (T.R.) had revenue of 153.00K ILS in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 306.00K. In the year 2024, Dna Group (T.R.) had annual revenue of 306.00K.
Revenue
306.00K
Revenue Growth
n/a
P/S Ratio
447.17
Revenue / Employee
n/a
Employees
21
Market Cap
136.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| SofWave Medical | 255.13M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |